Themis Medicare opened at ₹107.02, in line with its previous close of ₹107.02. During today's session, the stock has traded between ₹102.12 and ₹108.50, with an average traded price of ₹104.81. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Themis Medicare is now worth
₹ 11,609.00
giving a profit of
₹ 1,609.00 (16.09%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-0.30 (-0.28%)
Day High
₹108.50
Day Low
₹102.12
Day Open
₹107.02
Prev Close
₹107.02
Volume
66,745
Value Traded
₹0.70 Cr
1W Return
-5.47%
1M Return
-16.79%
3M Return
-8.76%
6M Return
27.67%
1Y Return
-18.42%
Market Cap (₹ Cr.)
983
PE Ratio
24.90
PB Ratio
2.72
Dividend Yield
0.47%
ROE
0.29%
ROCE
2.92%
Book Value (₹)
39.74
Face Value (₹)
1.00
EPS (TTM)
2.67
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-5.47%
6 Week
-
1 Month
-16.79%
3 Month
-8.76%
9 Month
12.22%
Themis Medicare shareholders approve ₹0.50 dividend for FY26
Dividend of ₹0.50 per equity share approved for FY26. Total dividend payout aggregates to ₹4.60 crore. Articles of Association amended to remove valuer requirement for certain share transfers.
13 days agoThemis Medicare withdraws ₹47 crore preferential issue plan
Themis Medicare Limited withdrew its proposed preferential issue of 45,95,795 convertible equity warrants. The warrants were priced at ₹102.87 each, intended for a promoter group entity. Working capital requirements, the primary goal of the issue, are now met by other means. Applications for in-principal approval to BSE and NSE will be withdrawn.
19 days agoThemis Medicare fixes Sep 23 record date for FY26 final dividend
Record date for FY26 final dividend fixed as September 23, 2026. Dividend payout requires approval at the 56th AGM on September 30, 2026. Disclosure made under SEBI Listing Regulations Regulation 42. Board meeting confirming the date was held on September 18, 2026.
25 days agoThemis Medicare updates Company Secretary and RTA contact emails
Themis Medicare Limited updated its Company Secretary and RTA email IDs on August 17, 2026. The new CS email is suresh.savaliya@themismedicare.com, and the RTA email is investor.helpdesk@in.mpms.mufg.com. The update was communicated to BSE and NSE by Chairman Dinesh S. Patel.
1mo agoThemis Medicare Q1 Results: Net profit up 287% YoY to ₹287.4 lakh
Themis Medicare Ltd posted a Q1FY27 standalone net profit of ₹287.4 lakh, reversing a ₹153.7 lakh loss in Q1FY26, driven by a ₹996.7 lakh exceptional gain from selling Gujarat Themis Biosyn shares. Core revenue fell 10.9% YoY to ₹869.6 lakh, while operational losses widened. The board also appointed Suresh Savaliya as Company Secretary.
2mo agoThemis Medicare Q1 Results: Net Loss Narrows to ₹569 Million
Themis Medicare’s Q1 results show a consolidated net loss of ₹569 million, improving from ₹139 million in the prior year. The EBITDA loss widened to ₹524 million from ₹101 million. The company benefited from a ₹929 million profit on the sale of shares, which offset operational losses.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Themis Medicare is now worth
₹ 11,609.00
giving a profit of
₹ 1,609.00 (16.09%)
Note: Past profits do not guarantee future returns.
